IRIS
CACCIOLA, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.332
EU - Europa 4.258
AS - Asia 2.016
SA - Sud America 646
Continente sconosciuto - Info sul continente non disponibili 239
AF - Africa 81
OC - Oceania 5
Totale 11.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.196
RU - Federazione Russa 2.257
SG - Singapore 818
CN - Cina 597
BR - Brasile 546
IE - Irlanda 493
IT - Italia 432
SE - Svezia 421
HK - Hong Kong 212
DE - Germania 156
VN - Vietnam 113
FR - Francia 105
GB - Regno Unito 83
FI - Finlandia 74
UA - Ucraina 71
IN - India 68
CA - Canada 58
PL - Polonia 52
AR - Argentina 38
BD - Bangladesh 36
BE - Belgio 27
MX - Messico 25
ZA - Sudafrica 25
JP - Giappone 24
TR - Turchia 21
ID - Indonesia 19
NL - Olanda 18
CO - Colombia 16
EC - Ecuador 15
AT - Austria 14
MA - Marocco 14
UZ - Uzbekistan 13
ES - Italia 12
IQ - Iraq 11
JM - Giamaica 11
CL - Cile 10
CR - Costa Rica 10
PK - Pakistan 10
PH - Filippine 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
DZ - Algeria 8
CZ - Repubblica Ceca 7
JO - Giordania 7
KE - Kenya 7
TN - Tunisia 7
LT - Lituania 6
MY - Malesia 6
PY - Paraguay 6
EG - Egitto 5
GR - Grecia 5
KZ - Kazakistan 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
GT - Guatemala 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
NI - Nicaragua 4
PA - Panama 4
UY - Uruguay 4
VE - Venezuela 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
IR - Iran 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
AO - Angola 2
BZ - Belize 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KR - Corea 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
TG - Togo 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LC - Santa Lucia 1
Totale 11.334
Salva come PNG Salva come JPEG
Città #
Ashburn 794
Moscow 642
Singapore 503
Dallas 494
Dublin 493
Chandler 294
San Jose 288
Nyköping 279
Hong Kong 211
Beijing 179
Messina 169
Jacksonville 148
Council Bluffs 134
Los Angeles 102
The Dalles 95
Ann Arbor 75
Princeton 67
Medford 62
New York 60
Lauterbourg 59
Munich 56
Des Moines 51
São Paulo 46
Dearborn 44
Warsaw 41
Cambridge 40
Ho Chi Minh City 39
Phoenix 38
Santa Clara 38
Boardman 31
Orem 31
Buffalo 27
Hanoi 26
Tianjin 26
Brussels 24
Jinan 24
Tokyo 22
Frankfurt am Main 21
Redondo Beach 21
Atlanta 19
Houston 19
Rio de Janeiro 19
Rome 19
Rosolini 19
Turku 19
Woodbridge 19
Brooklyn 18
Seattle 18
Belo Horizonte 17
Chicago 17
Helsinki 17
Hyderabad 17
Nuremberg 17
Catania 16
Guangzhou 16
Shanghai 16
Denver 15
Nanjing 15
Milan 14
San Francisco 14
Amsterdam 13
Montreal 13
Chennai 12
Columbus 12
San Mateo 12
Wilmington 12
Hebei 11
Jakarta 11
Johannesburg 11
Pune 11
Brasília 10
Mexico City 10
Porto Alegre 10
Shenyang 10
Avola 9
Hangzhou 9
San José 9
Shenzhen 9
Vienna 9
Ankara 8
Boston 8
Dhaka 8
Haikou 8
Mumbai 8
Palermo 8
Tashkent 8
Baku 7
Bremen 7
Guayaquil 7
Haiphong 7
Kingston 7
London 7
Pachino 7
Salvador 7
Stockholm 7
Toronto 7
Baghdad 6
Cape Town 6
Düsseldorf 6
Las Vegas 6
Totale 6.507
Salva come PNG Salva come JPEG
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 283
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 282
Atrial fibrillation in patients with cirrhosis 267
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 235
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 226
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 226
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 218
Erectile dysfunction in compensated liver cirrhosis 218
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 214
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 207
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 204
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 204
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 199
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 198
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 195
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 188
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 182
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 181
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 180
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 180
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 179
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 178
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 176
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 174
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 171
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 169
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 167
Oscillazione dei livelli di viremia in soggetti portatori cromici asintomatici di infezione da virus B. Dati preliminari 164
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 164
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 162
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 162
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 160
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 159
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 157
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 152
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 152
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 149
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 147
Oscillazione dei livelli di viremia in soggetti portatori cronici asintomatici di infezione da virus b. Dati preliminari 147
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 144
Fever and rhomboid target lesion in decompensated cirrhosis 143
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 142
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 141
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 136
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 136
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 135
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 135
Dermatiti iatrogene in corso di trattamento dell’epatopatia HCV-correlata con simeprevir 134
Strain endocardico longitudinale tra pazienti cirrotici di classe A e B al punteggio di Child-Pugh 132
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 129
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 126
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 126
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 125
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 122
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 121
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 121
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 117
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 113
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 112
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 111
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience 111
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 111
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 110
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. 107
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 104
PREVALENCE OF BACTERIAL RESISTANCE IN CIRRHOTIC PATIENTS WITH BACTERIAL INFECTION: A PRELIMINARY REPORT 103
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 100
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 98
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 88
Occult hepatitis B virus infection 84
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 80
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies 76
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 45
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 44
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression 34
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial 27
null 22
The Innovative Potential of Artificial Intelligence Applied to Patient Registries to Implement Clinical Guidelines 21
null 20
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B 17
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy 17
From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients 17
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus 16
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolizationfor Hepatocellular Carcinoma: An Observational Multicenter Study 13
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 11
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort 9
Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening 8
Metabolic Dysfunction-Associated Steatotic Liver Disease: An Underrated and Emerging Cardiovascular Risk Factor 7
Totale 11.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 0 0 14 36 4 52 11 7 66 65 146
2022/20231.347 81 162 73 89 86 127 32 77 556 7 37 20
2023/2024340 27 61 20 36 31 44 7 10 3 44 18 39
2024/20251.668 30 27 44 118 77 71 83 326 378 89 167 258
2025/20265.688 278 467 420 357 433 1.104 700 699 732 283 83 132
2026/20271.002 168 208 271 355 0 0 0 0 0 0 0 0
Totale 11.577